<DOC>
	<DOCNO>NCT01947478</DOCNO>
	<brief_summary>The purpose trial ass safety efficacy MDT-2113 interventional treatment de novo non-stented restenotic lesion superficial femoral artery ( SFA ) proximal popliteal artery ( PPA ) compare treatment standard percutaneous transluminal angioplasty ( PTA ) .</brief_summary>
	<brief_title>MDT-2113 Drug-Eluting Balloon vs. Standard PTA Treatment Atherosclerotic Lesions Superficial Femoral Artery and/or Proximal Popliteal Artery</brief_title>
	<detailed_description />
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<criteria>Age : ≥ 20 year ≤ 85 year Documented ischemia Rutherford classification 2 , 3 , 4 Able walk without assistive device Target lesion SFA and/or PPA knee Target lesion consist single de novo nonstented restenotic lesion ( tandem lesion ) combination lesion meet follow criterion : 1 . ≥ 70 % &lt; 100 % occlude total lesion length ≥ 40 mm ≤ 200 mm 2 . 100 % occlude total lesion length ≤100 mm 3 . Combination lesion must total lesion length ≥40 mm ≤200 mm occlude segment ≤ 100 mm length ( visual estimate ) Reference vessel diameter ≥ 4 mm ≤7 mm ( visual estimate ) Angiographic evidence adequate distal runoff foot Stroke STEMI within 3 month prior enrollment Either local systemic thrombolytic therapy within 48 hour prior index procedure Inability tolerate oral anticoagulation therapy ( blood thinner warfarin ) concomitant dual antiplatelet therapy ( DAPT ) Known allergy sensitivities heparin , aspirin ( ASA ) , anticoagulant/antiplatelet therapy paclitaxel , allergy contrast medium adequately pretreated prior index procedure Chronic renal insufficiency Subject enrol another investigational device , drug , biologic study Any major surgical procedure intervention perform within 30day period prior post index procedure Contralateral SFA/PPA disease require treatment set index procedure Failure successfully cross target lesion Angiographic evidence severe calcification Target lesion know advance enrollment require treatment alternative therapy stenting , laser , atherectomy , cryoplasty , brachytherapy , reentry device , cut balloon , score balloon ; use embolic protection device also prohibit</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Drug-Eluting Angioplasty Balloon</keyword>
	<keyword>Drug Coated Angioplasty Balloon</keyword>
	<keyword>Peripheral Artery Disease</keyword>
	<keyword>Experimental</keyword>
	<keyword>Percutaneous Transluminal Angioplasty ( PTA )</keyword>
</DOC>